APLLTDPharmaceuticals
Alembic Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹663.25
-2.97%
Current P/E28.12xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E31.9x11.9% below avg
✅
11.5% Discount to Industry
APLLTD P/E 28.12x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹29.68 | ₹846 | 28.5x |
| 2024 | ₹31.33 | ₹1066 | 34x |
| 2023 | ₹17.40 | ₹759 | 43.6x |
| 2022 | ₹26.50 | ₹573 | 21.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Alembic Pharmaceuticals Ltd Valuation
Alembic Pharmaceuticals Ltd (APLLTD) currently trades at 28.12x earnings. The Pharmaceuticals sector average PE is 31.77x. APLLTD is trading at a discount to peers — may indicate relative value. Historically, APLLTD has traded at an average PE of 31.9x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
11.38%
Dividend Yield
1.21%
More on Alembic Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.